54 posters,  8 sessions,  14 topics,  53 authors,  38 institutions
ePostersLive® by SciGen® Technologies S.A. All rights reserved.

LB01
Randomized, Placebo-Controlled Trial of FOND (fosaprepitant, ondansetron, dexamethasone) Versus FOND+O (FOND plus olanzapine) for the Prevention of Chemotherapy Induced Nausea and Vomiting in Hematology Patients Receiving Highly Emetogenic Chemotherapy...

Poster Presenter
Authors
Affiliations

Rate

No votes yet

Randomized, Placebo-Controlled, Phase III trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) versus FOND plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Highly Emetogenic Chemotherapy: The FOND-O Trial

 

Enter Poster ID (e.gGoNextPreviousCurrent